These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 17384639
1. Proteome analysis of soluble nuclear proteins reveals that HMGB1/2 suppress genotoxic stress in polyglutamine diseases. Qi ML, Tagawa K, Enokido Y, Yoshimura N, Wada Y, Watase K, Ishiura S, Kanazawa I, Botas J, Saitoe M, Wanker EE, Okazawa H. Nat Cell Biol; 2007 Apr; 9(4):402-14. PubMed ID: 17384639 [Abstract] [Full Text] [Related]
2. Isolation of gene sets affected specifically by polyglutamine expression: implication of the TOR signaling pathway in neurodegeneration. Nelson B, Nishimura S, Kanuka H, Kuranaga E, Inoue M, Hori G, Nakahara H, Miura M. Cell Death Differ; 2005 Aug; 12(8):1115-23. PubMed ID: 15861189 [Abstract] [Full Text] [Related]
3. VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration. Hirabayashi M, Inoue K, Tanaka K, Nakadate K, Ohsawa Y, Kamei Y, Popiel AH, Sinohara A, Iwamatsu A, Kimura Y, Uchiyama Y, Hori S, Kakizuka A. Cell Death Differ; 2001 Oct; 8(10):977-84. PubMed ID: 11598795 [Abstract] [Full Text] [Related]
4. Differential proteomic analysis of nuclear extracts from thyroid cell lines. Salzano AM, Paron I, Pines A, Bachi A, Talamo F, Bivi N, Vascotto C, Damante G, Quadrifoglio F, Scaloni A, Tell G. J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar 20; 833(1):41-50. PubMed ID: 16431169 [Abstract] [Full Text] [Related]
5. Expanded polyglutamine domain possesses nuclear export activity which modulates subcellular localization and toxicity of polyQ disease protein via exportin-1. Chan WM, Tsoi H, Wu CC, Wong CH, Cheng TC, Li HY, Lau KF, Shaw PC, Perrimon N, Chan HY. Hum Mol Genet; 2011 May 01; 20(9):1738-50. PubMed ID: 21300695 [Abstract] [Full Text] [Related]
6. Multi-domain misfolding: understanding the aggregation pathway of polyglutamine proteins. Saunders HM, Bottomley SP. Protein Eng Des Sel; 2009 Aug 01; 22(8):447-51. PubMed ID: 19589877 [Abstract] [Full Text] [Related]
7. Polyglutamine expansion of huntingtin impairs its nuclear export. Cornett J, Cao F, Wang CE, Ross CA, Bates GP, Li SH, Li XJ. Nat Genet; 2005 Feb 01; 37(2):198-204. PubMed ID: 15654337 [Abstract] [Full Text] [Related]
8. Age-dependent change of HMGB1 and DNA double-strand break accumulation in mouse brain. Enokido Y, Yoshitake A, Ito H, Okazawa H. Biochem Biophys Res Commun; 2008 Nov 07; 376(1):128-33. PubMed ID: 18762169 [Abstract] [Full Text] [Related]
9. Expanded polyglutamine stretches lead to aberrant transcriptional regulation in polyglutamine diseases. Shimohata T, Onodera O, Tsuji S. Hum Cell; 2001 Mar 07; 14(1):17-25. PubMed ID: 11436350 [Abstract] [Full Text] [Related]
10. Evidence for sequestration of polyglutamine inclusions by Drosophila myeloid leukemia factor. Kim WY, Fayazi Z, Bao X, Higgins D, Kazemi-Esfarjani P. Mol Cell Neurosci; 2005 Aug 07; 29(4):536-44. PubMed ID: 15936212 [Abstract] [Full Text] [Related]
11. Identification of ter94, Drosophila VCP, as a modulator of polyglutamine-induced neurodegeneration. Higashiyama H, Hirose F, Yamaguchi M, Inoue YH, Fujikake N, Matsukage A, Kakizuka A. Cell Death Differ; 2002 Mar 07; 9(3):264-73. PubMed ID: 11859409 [Abstract] [Full Text] [Related]
12. PolyQ fibrillation in the cell nucleus: who's bad? von Mikecz A. Trends Cell Biol; 2009 Dec 07; 19(12):685-91. PubMed ID: 19796946 [Abstract] [Full Text] [Related]
13. [Polyglutamine diseases: a pathologic view]. Yamada M. Rinsho Shinkeigaku; 2003 Nov 07; 43(11):903-5. PubMed ID: 15152499 [Abstract] [Full Text] [Related]
14. High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo. Faraco G, Fossati S, Bianchi ME, Patrone M, Pedrazzi M, Sparatore B, Moroni F, Chiarugi A. J Neurochem; 2007 Oct 07; 103(2):590-603. PubMed ID: 17666052 [Abstract] [Full Text] [Related]
15. Transcriptional repression and cell death induced by nuclear aggregates of non-polyglutamine protein. Fu L, Gao YS, Sztul E. Neurobiol Dis; 2005 Dec 07; 20(3):656-65. PubMed ID: 15964198 [Abstract] [Full Text] [Related]
16. Overexpression of high mobility group (HMG) B1 and B2 proteins directly correlates with the progression of squamous cell carcinoma in skin. Sharma A, Ray R, Rajeswari MR. Cancer Invest; 2008 Oct 07; 26(8):843-51. PubMed ID: 18798064 [Abstract] [Full Text] [Related]
17. p97 Homologs from Caenorhabditis elegans, CDC-48.1 and CDC-48.2, suppress the aggregate formation of huntingtin exon1 containing expanded polyQ repeat. Nishikori S, Yamanaka K, Sakurai T, Esaki M, Ogura T. Genes Cells; 2008 Aug 07; 13(8):827-38. PubMed ID: 18782221 [Abstract] [Full Text] [Related]
18. Enhanced SUMOylation in polyglutamine diseases. Ueda H, Goto J, Hashida H, Lin X, Oyanagi K, Kawano H, Zoghbi HY, Kanazawa I, Okazawa H. Biochem Biophys Res Commun; 2002 Apr 26; 293(1):307-13. PubMed ID: 12054600 [Abstract] [Full Text] [Related]
19. [Differential proteomic analysis and function study of human prostate carcinoma cells with different osseous metastatic tendency]. Song DX, Chen AM, Guo FJ, Liao H, Xie BZ, Zhu B, Chen C. Zhonghua Yi Xue Za Zhi; 2008 Apr 29; 88(17):1197-201. PubMed ID: 18844116 [Abstract] [Full Text] [Related]